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Abstract
Background: Scabies, a parasitic disease of the skin, is a major public health problem, largely affecting children.
Scabies is often complicated by impetigo which can result in serious complications including invasive infections
and immune mediated diseases. Scabies and impetigo are reported to have high prevalence in tropical settings
including the Solomon Islands.
Methods: We conducted a cross-sectional prevalence survey at Gizo Primary School in the Western Province of the
Solomon Islands in August 2018. The diagnosis of scabies was based on criteria developed by the International
Alliance for the Control of Scabies in 2018. Population attributable risk was calculated to determine the effect of
scabies on the prevalence of impetigo, and both adjusted and unadjusted risk ratios were calculated to identify
differences between sexes and age groups.
Results: A total of 324 students were assessed (47.5% of those enrolled at the school). The prevalence of scabies
was 54.3% (95% confidence interval [CI] 48.7–59.8) and most disease was mild (68.8%). The prevalence was higher
in males (63.5%; adjusted risk ratio [ARR] 1.4, 95% CI 1.1–1.7), and in those aged 10–12 years (61.4%; ARR 1.8, 95% CI
1.1–2.9 when compared to those aged 4–6 years). The prevalence of impetigo was 32.1%, with males more likely to
be affected (41.7%, ARR 1.7, 95% CI 1.2–2.4) but with no significant differences between age groups. 63.5% of those
with impetigo had scabies, corresponding to a population attributable risk of 11.8%.
Conclusions: There is a very high burden of scabies and impetigo among primary school students in Gizo. There is
a critical need for the development and implementation of control programs in areas where scabies is endemic.
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Background
Sarcoptes scabiei var. hominis is a parasitic mite that
burrows into human skin. Infestation with the mite
results in an inflammatory reaction producing skin
lesions with severe pruritus. Persistent scratching results
in broken skin, compromising its barrier function and
facilitating secondary bacterial infection with group A
Streptococcus (GAS; Streptococcus pyogenes) or with
Staphylococcus aureus, presenting as impetigo. Impetigo
may progress to severe skin and soft tissue infection,
bone and joint infection, sepsis or the immune-
mediated complications of GAS infection such as
glomerulonephritis and potentially rheumatic fever [1, 2].
Although a range of effective treatment options for scabies
exists, the highly contagious nature of the disease makes
its public health control challenging.
Scabies is estimated to affect more than 200 million
people, especially children [3, 4]. Despite these estimates,
a major barrier for global disease control is the scarcity
of epidemiologic data [5, 6]. Prevalence surveys using
systematic and standardized methods are likely to be a
crucial component in determining the global burden of
disease and identifying areas where the disease is
endemic. The International Alliance for the Control of
Scabies (IACS) undertook a Delphi study in order to
establish consensus diagnostic criteria for scabies [7].
The 2018 IACS Criteria provide standardized diagnostic
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methods to enable evaluation and comparison of global
prevalence data.
Schools have been a focus for both surveillance and
control of neglected tropical diseases (NTDs), including
schistosomiasis and soil-transmitted helminthiases [8].
School screening studies conducted in Africa and Asia
have investigated the burden of scabies, either in isola-
tion, or in conjunction with other NTDs or skin condi-
tions [9, 10] but there have been no school-based studies
from the Solomon Islands. Locally relevant epidemio-
logical evidence of the burden of scabies is required for
the design and implementation of community scabies
control programs. The primary objective of this study
was therefore to determine the prevalence of scabies and
impetigo in the population examined using a school
screening method. The secondary objectives were to in-
vestigate features associated with scabies and impetigo.
We also aimed to describe the severity of scabies and
impetigo and the distribution of scabies cases using the
2018 IACS Criteria subcategories.
Methods
Study setting and participants
This was a cross-sectional, school-based study that took
place in the public primary school in the town of Gizo,
the capital of the Western Province of the Solomon
Islands. The population in the Gizo region is approxi-
mately 7000 [11]. The setting was selected because it is
the site of a planned trial. The school was selected as the
study site because of the simple facilitation of recruit-
ment of participants within a school setting and its con-
venient location within the centre of the town.
At the commencement of 2018, the primary school
had a school roll of 682 students, consisting of students
residing in Gizo town and those who travel by truck or
boat from surrounding villages or islands. Students at
the primary school are aged 4 to 15 years, with class
groupings based on aptitude rather than age.
Study procedures
All students attending Gizo Primary School were eligible
for inclusion in the study. All patients underwent a stan-
dardized examination for scabies and impetigo.
Clinical assessment was performed by doctors with ex-
pertise in scabies diagnosis, and by nurses with clinical
experience in scabies diagnosis, supplemented by a train-
ing program on the diagnosis of scabies, impetigo and
other locally common skin conditions. Scabies was diag-
nosed using the 2018 IACS Criteria [7]. Although eight
subcategories exist in the IACS Criteria, only four were
relevant for diagnosis in this study (Table 1). Subcat-
egories of diagnosis that required specialized equipment
(including microscopy and dermoscopy) or required
examination of the genitals, were not used, as these were
not practical for a field survey in this context. Impetigo
was diagnosed on the presence of papules, pustules or
ulcerative lesions with associated erythema, crusting or
pus. Skin examination consisted of assessment of ex-
posed areas: the feet and legs to the thighs, hands to the
upper arms, neck, face and scalp. Students were in
school uniform which consisted of above-knee shorts
and above-elbow shirts or dresses. Shoes were removed
prior to examination. A focused history of standardized
questions was taken of all participants with skin lesions
consisting of information required for the IACS Criteria
classification. Questions included whether participants
experienced itch. Contact history was assessed by asking
if participants lived with someone, or had a friend or
classmate with itch, or if they lived with someone, or
had a friend or classmate with a rash that looks like sca-
bies. Participants were shown images of people with typ-
ical scabies rashes to assist these questions. History was
Table 1 Case definitions for scabies using the 2018 IACS Criteria
Criteria Category Used in Survey
Confirmed scabies
A1: Mites, eggs or feces on light microscopy of skin samples No
A2: Mites, eggs or feces visualized on individual using high powered imaging device No
A3: Mite visualized on individual using dermoscopy No
Clinical Scabies
B1: Presence of burrows Yes*
B2: Typical lesions affecting male genitalia No
B3: (Typical lesions) and (typical distribution) and (itch) and (contact history) Yes
Suspected Scabies
C1: (Typical lesions) and (typical distribution) and (itch) or (contact history) Yes
C2: (Atypical lesions) or (atypical distribution) and (itch) and (contact history) Yes
* If burrows were identified, individuals were also classified as either B3, C1, or C2, as these were not confirmed with dermoscopy
A diagnosis of scabies should only be made if other differential diagnoses are considered less likely than scabies.
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taken in the local language (Solomon Islands Pijin). Per-
methrin was supplied for individuals diagnosed with sca-
bies. Permethrin was also supplied for household
contacts of diagnosed children, as per local treatment
protocol. No treatment was supplied to examined chil-
dren without scabies. If other conditions were diagnosed,
referral was provided to the local health clinic.
Data collection and statistical methods
Demographic information was collected including par-
ticipant age, sex and school grade.
Scabies diagnosis was classified into one of three IACS
Criteria subcategories (Table 1).
Following methods used in previous studies, severity
of scabies and impetigo was assessed based on the num-
ber of lesions present [12, 13]. Scabies was categorized
as: mild, 1 to 10 lesions; moderate, 11 to 49 lesions; or
severe, 50 or more lesions. Impetigo was classified as:
very mild, 1 to 5 lesions; mild, 6 to 10 lesions; moderate,
11 to 49 lesions; or severe, 50 or more lesions.
Prevalence for scabies and impetigo was calculated for
each demographic group. Risk ratios were calculated
using generalized linear models, adjusting for age
group and sex. Population attributable risk was calcu-
lated to further analyze association between scabies
and impetigo [14].
Data were collected on forms during the study period
and then transcribed and uploaded to a REDCap study
database (Research Electronic Data Capture), hosted at
Murdoch Children’s Research Institute [15]. All statis-
tical analysis was performed using Stata (version 15, Sta-
taCorp, College Station, TX, USA).
Ethics statement
Parents were provided with written information regard-
ing the study. A community information night was also
held at the school where members of the study team
provided further information and answered questions.
Written consent was obtained from parents or guardians
of all participants and verbal assent from children where
possible.
Ethical approval was granted by the Royal Children’s
Hospital Melbourne Human Research Ethics Committee
(reference number 38099A) and the Solomon Islands
Health Research and Ethics Review Board (reference
number 05/18).
Results
Over 6 days in August 2018, 324 students were recruited
and examined (47.5% of those enrolled at the school).
All consenting students present at school during study
days were examined. Doctors examined 247 participants
(76.2%) and the remainder were examined by trained
nurse examiners. Of those examined, 51.9% were female
and the mean age was 9.6 years (standard deviation 2.3,
range 4–15; Table 2).
Scabies and impetigo prevalence
Overall, 176 participants had scabies (prevalence 54.3,
95% confidence interval [CI] 48.7–59.8), and 104 partici-
pants had impetigo (prevalence 32.1, 95% CI 27.0–37.5).
Most scabies cases were mild (68.8%, n = 121) but 14
participants (8%) had severe scabies (Table 3). The ma-
jority of those with impetigo had very mild disease (n =
86, 82.7%, Table 3). The prevalence of scabies diagnosed
by doctor and nurse examiners was similar (52.2, 95% CI
45.8–58.6; vs 61.0, 95% CI 49.2–72.0%).
History features
Itch was reported in 81.8% of individuals with scabies
(n = 144) and in 18.4% of those without scabies (n = 21,
missing = 34). A positive contact history was reported in
92.1% (n = 161) of those with scabies, and in 52.6% of
those without scabies who were asked (n = 60, missing =
34). The most common contact history reported was
having a friend or classmate with a rash that looks like
scabies (75, 95%CI 67.9–81.2, Table 4). Of those with
scabies, 26.1% (n = 46) reported either a history of itch
or a positive contact history and 73.9% (n = 130) had
both history features. Of those without scabies, 46.5%
(n = 53) reported either a history of itch or a positive
contact history and 12.3% (n = 14) had both features.
IACS criteria
The majority of scabies cases (n = 128, 72.7%) were clas-
sified as Clinical Scabies, subcategory B3, with typical
clinical features, itch and contact history according to
the IACS Criteria (Table 3). Only four individuals (2.3%)
were identified to have clinically visible burrows (B1).
Associations with scabies and impetigo
Scabies was more common in males than females (63.5% vs
45.8%, adjusted risk ratio [ARR] 1.4, 95% CI 1.1–1.7; Table 2)
and the most commonly affected age group was children
aged 10–12 years (61.4%; ARR 1.8, 95% CI 1.1–2.9, compared
to age group 4–6 years; Fig. 1). Prevalence of impetigo was
higher in males (41.7% vs 23.2%, ARR 1.7, 95% CI 1.2–2.4)
but similar across age groups.
Participants with scabies had a higher prevalence of
impetigo than those without scabies (66 of 176, 37.5% vs
38 of 110, 25.7%, ARR 1.5, 95% CI 1.1–2). Overall, 63.5%
of those with impetigo had scabies, corresponding to a
population attributable risk of 11.8% (95%CI 1.7–21.7,
P = 0.02). Of the 18 individuals with greater than very
mild impetigo, 14 (77.8%) had scabies, and of the indi-
viduals with moderate to severe impetigo, all had scabies
(n = 6, 100%).
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Discussion
Our study highlights the very high prevalence of scabies
(54%) and impetigo (32%) in school-aged children in
Gizo. The prevalence of scabies is higher than a previous
study conducted in the same region in 2014 which re-
ported a prevalence of 23% in children aged 5 to 14
[12]. High scabies prevalence has been described in
other disadvantaged populations including in children
in Fiji (55.7%) [13], rural communities in Nigeria
(65%) [16] and amongst asylum seekers in the
Netherlands (33.5%) [17].
In our study, males were more likely than females to
have scabies, which has been reported previously [18,
19], although this finding is not represented in the Glo-
bal Burden of Disease Study (2015) estimates [20].
The majority of scabies seen was classified as Clinical
Scabies according to the 2018 IACS Criteria (Fig. 2).
This was consistent for males and females. Very few sca-
bies cases (4%) had either atypical lesions or an atypical
distribution of their rash. We found that the 2018 IACS
Criteria for the diagnosis of scabies were easily in-
tegrated and implemented into our study design.
Table 2 Participant demographics and prevalence of scabies and impetigo (N = 324)
Study Sample Scabies Impetigo
N (%) n % (95%CI) Adjusted RR (95%CI) n % (95%CI) Adjusted RR (95%CI)
Sex
Female 168 (51.9) 77 45.8 (38.1-53.7) Ref 39 23.2 (17.1-30.3) Ref
Male 156 (48.2) 99 63.5 (55.4-71.0) 1.4 (1.1-1.7) 65 41.7 (33.8-49.8) 1.7 (1.2-2.4)
Age (Years)
4-6 35 (10.8) 12 34.3 (19.1-52.2) Ref 14 40.0 (23.9-57.9) Ref
7-9 121 (37.4) 66 54.5 (45.2-63.6) 1.6 (1.0-2.6) 44 36.4 (27.8-45.6) 1 (0.6-1.5)
10-12 132 (40.7) 81 61.4 (52.5-69.7) 1.8 (1.1-2.9) 35 26.5 (19.2-34.9) 0.7 (0.5-1.2)
13-15 36 (11.1) 17 47.2 (30.4-64.5) 1.4 (0.8-2.5) 11 30.6 (16.3-48.1) 0.8 (0.4-1.5)
Table 3 Details of diagnosis and severity for scabies and impetigo
Overall
(N = 324)
Male
(N = 156)
Female
(N = 168)
Age
Years 4–6
(N = 35)
Age
Years 7–9
(N = 121)
Age
Years 10–12
(N = 132)
Age
Years 13–15
(N = 36)
Scabies n (%) n (%) n (%) n (%) n (%) n (%) n (%)
Prevalence 176 (54.3) 99 (63.5) 77 (45.8) 12 (34.3) 66 (54.6) 81 (61.4) 17 (47.2)
Category
B1: Burrows* 4 (2.3) 2 (2) 2 (2.6) 0 (0) 0 (0) 3 (3.7) 1 (5.9)
B3: Clinical scabies 128 (72.7) 73 (73.7) 55 (71.4) 9 (75) 47 (71.2) 64 (79) 8 (47.1)
C1: Suspected scabies 41 (23.3) 25 (25.2) 16 (20.8) 3 (25) 16 (24.2) 13 (19.7) 9 (52.9)
C2: Suspected scabies 7 (4) 1 (1) 6 (7.8) 0 (0) 3 (4.5) 4 (6.1) 0 (0)
Severity
Mild (1–10) 121 (68.8) 67 (67.7) 54 (70.1) 8 (66.7) 46 (69.7) 53 (65.4) 14 (82.4)
Moderate (11–49) 41 (23.3) 22 (22.2) 19 (24.7) 4 (33.3) 15 (22.7) 20 (24.7) 2 (11.8)
Severe (≥ 50) 14 (8) 10 (10.1) 4 (5.2) 0 (0) 5 (7.6) 8 (9.9) 1 (5.9)
Impetigo n (%) n (%) n (%) n (%) n (%) n (%) n (%)
Prevalence 104 (32.1) 65 (41.7) 39 (23.2) 14 (40) 44 (36.4) 35 (26.5) 11 (30.6)
Severity
Very Mild (≥ 5) 86 (82.7) 52 (80.0) 34 (87.2) 12 (85.7) 39 (88.6) 25 (71.4) 10 (90.9)
Mild (6–10) 12 (11.5) 8 (12.3) 4 (10.3) 2 (14.3) 4 (9.1) 6 (17.1) 0 (0)
Moderate (11–49) 3 (2.9) 2 (3.1) 1 (2.6) 0 (0) 0 (0) 2 (5.7) 1 (9.1)
Severe (≥50) 3 (2.9) 3 (4.6) 0 (0) 0 (0) 1 (2.3) 2 (5.7) 0 (0)
*Individuals with burrows were additionally categorized as either B3, C1 or C2
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Implementation of these criteria in other settings would
allow comparison across studies and regions.
The high prevalence of impetigo (32%) is consistent
with other studies from Pacific Island nations, including
in Fiji (26%) and a previous study in the Solomon Islands
(33%) [12, 21]. Most of the impetigo (82%) in this study
was very mild, consistent with other studies [12, 13].
Impetigo was positively associated with the presence of
scabies, although the association was less strong than
previously reported [13]. The association between sca-
bies and impetigo in a range of settings warrants further
investigation.
Itch was reported by 82% of participants with scabies,
which is consistent with other studies (72–100%) [16,
17, 22–26]. A positive contact history was reported in
92% of participants with scabies. In those with scabies,
itch was reported to occur in 43% of household
members, similar to other studies (50–55%) [22, 24].
However, in our study, more children identified contact
with a friend or class member than a household mem-
ber. Contact between children at school and between
friends is likely to be important for disease transmission
between children. Contact history questions should be
asked in an appropriate way for specific survey settings
and participants.
There were several limitations to our study. First, this
study only focused on school children and is therefore
not generalizable to other age groups. However, as sca-
bies is highly transmissible among household contacts
[27] it is likely that there would be a high prevalence
amongst the household members of children with sca-
bies. Second, we enrolled 47.5% of students on the
school roll, which may have introduced participation
bias. The remaining students did not participate because
they were away from school or did not provide consent
to participate. Those not attending school may have
Table 4 Reporting of history features
Total (N = 290) With scabies (N = 176) Without scabies (N = 114)
Itch n % (95%CI) n % (95%CI) n % (95%CI)
Itch present 165 56.9 (51–62.7) 144 81.8 (75.3–87.2) 21 18.4 (11.8–26.8)
Contact History
House contact with itch 97 33.5 (28–39.2) 76 43.2 (35.8–50.8) 21 18.4 (11.8–26.8)
School contact with itch 152 52.4 (46.5–58.3) 117 66.5 (59–73.4) 35 30.7 (22.4–40)
House contact with scabies rash 76 27.2 (22.2–32.8) 65 36.9 (29.8–44.5) 14 12.3 (6.9–19.7)
School contact with scabies rash 177 61 (55.2–66.7) 132 75 (67.9–81.2) 45 39.5 (30.4–49.1)
Contact history positive* 222 76.6 (71.2–81.3) 162 92.1 (87–95.5) 60 52.6 (43.1–62.1)
*Contact history was considered positive if responses to any of the four questions were positive
Fig. 1 Prevalence of scabies and impetigo by age group with 95% confidence intervals
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been more disadvantaged with an even greater disease
burden, possibly leading to an underestimate of the true
prevalence. Conversely, it is possible that some families
and teachers may have encouraged children with symp-
toms of scabies or impetigo to participate, which may
have led to an overestimate of prevalence. Third, the
diagnosis of scabies and impetigo in the study was based
on clinical assessment of exposed areas utilizing the
IACS Criteria, rather than whole body examination
using dermoscopy, microscopy, or skin scrapings.
Limited examination may have underestimated the true
prevalence, perhaps by up to 10% [28], whereas reliance
on clinical signs may have led to some misclassification
and overestimate of disease.
Children in low-resource settings are disproportion-
ately affected by scabies and impetigo, predisposing
them to significant morbidity and mortality. The high
prevalence of scabies in this study supports the ongoing
need for prevalence studies and identifying communities
where the disease is endemic. The significant burden of
disease highlights the need for ongoing health promo-
tion activities for scabies and impetigo. The very high
prevalence of scabies also supports the urgent imple-
mentation of a population-scale control program in the
Solomon Islands. Greater appreciation of scabies as a
major global contributor to poor health in children may
help to improve awareness and access to treatment in
settings where scabies is endemic.
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